EATONTOWN, NJ / ACCESSWIRE / December 22, 2021 / American CryoStem Corporation (OTC PINK:CRYO) a clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and
now, and if not, when will they and what will they do? well, they re in an experimental phase, running clinical trials. there are monoclonal antibodies which do work. if you re in a high risk category and you just got diagnosed with covid-19, ask about getting a monoclonal antibody infusion that may keep you from getting really sick and ending up in the hospital. the nasal spray version is appealing because it doesn t require an intravenous infusion, and the pills, the next thing we want to push hard on, and you mentioned in the opening the announcement this week that the white house is putting $3 billion into a major effort to develop these highly effective and safe oral agents, pills, that you can take immediately after getting a positive test that would basically knock that virus out. this is a hard problem. this takes all of the skills of the public and the private sector working together.
American CryoStem Announces Patient Biomaterial Processing for its Post-Concussion Syndrome (PCS) Phase I Clinical Trial phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.
American CryoStem Announces Patient Biomaterial Processing for its Post-Concussion Syndrome (PCS) Phase I Clinical Trial saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.